Skip to content
Screener

CareDx CDNA EPS (Diluted)

EPS (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.68+9.3%
Natera, Inc. logo
Natera, Inc.NTRA
-$0.47+36.5%
Insight Molecular Diagnostics Inc. logo
Insight Molecular Diagnostics Inc.IMDX
-$0.12+53.8%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$0.29-61.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$0.80-116%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$19.55-954%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.32B+218%
Enterprise value$2.26B+228%
P/S5.6×+3.5×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Income tax benefit (expense)32(58)
Net income (loss)$2,809$(10,353)
Net income (loss) per share (Note 3):
Basic$0.05$(0.19)
Diluted$0.05$(0.19)
Weighted-average shares used to compute net income (loss) per share:
Basic51,151,79455,262,459
Diluted53,129,92855,262,459

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's EPS (diluted)?
CareDx (CDNA) reported EPS (diluted) of $0.05 in Q1 2026.
How has CareDx's EPS (diluted) changed year-over-year?
CareDx's EPS (diluted) increased by 126.3% year-over-year, from -$0.19 to $0.05.
What is the long-term trend for CareDx's EPS (diluted)?
Over 4 years (2021 to 2025), CareDx's EPS (diluted) has grown at a -9.3% compound annual growth rate (CAGR), from -$0.59 to -$0.40.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about CareDx's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude